Case Series
Identification and Treatment of Complex Regional Pain Syndrome-Not Otherwise Specified (CRPS-NOS) with Peripheral Sympathetic Nerve Blockade: A Case Series
Carden E, Fanning MT, Sparley K and Horrigan J
1Southern California Academic Pain Management Institute/RSD Institute USA
2Tactical Sports Medicine Department, Southern California University of Health Science (SCU) USA
2Tactical Sports Medicine Department, Southern California University of Health Science (SCU) USA
*Corresponding author:Michael T. Fanning, Tactical Sports Medicine Department, Southern California University of Health Science (SCU) USA E-mail Id: MichaelFanning@scuhs.edu
Article Information:Submission: 14/05/2024; Accepted: 04/06/2024; Published: 06/06/2024
Copyright: © 2024 Carden E, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction:Complex Regional Pain Syndrome (CRPS) is a pain condition that is often controversial in definition and treatment approach. While early identification of the disease process is important for treatment, current diagnostic criterium is particular on qualifying signs and symptoms. The restrictive nature the different consensus criterium may leave a patient without a diagnosis, and without effective treatment.
Methods:This case series details twelve patients that do not fall into the typical CRPS-I and II case presentation, diagnostic criteria and might not otherwise receive a CRPS diagnosis. These patients would more likely fall into a CRPS-NOS (not otherwise specified) diagnosis because they do not meet all of the criterium. Not considering CRPS-NOS as a diagnosis could ultimately lead to an inaccurate diagnosis, ineffective treatment, and poor long-term outcomes.
Results:During a fourteen-month period, patients that were experiencing multiple symptoms of CRPS were identified and referred to a CRPS specialist for confirmatory diagnosis and treatment. Each of the patients underwent a series of peripheral sympathetic nerve blocks which ceased, or at least significantly decreased, patient symptomatology.
Conclusion:This case series is a small sample size of patients that were successfully treated with a series of peripheral sympathetic nerve blocks and adjunct therapy for CRPS. CRPS is a difficult disease process to manage, often with invasive means of treatment such as sympathetic ganglion blockade, intrathecal pump, spinal cord stimulator and/or pharmacologics. Peripheral sympathetic nerve blockade can be a powerful diagnostic and treatment tool for patients suffering from CRPS.
Methods:This case series details twelve patients that do not fall into the typical CRPS-I and II case presentation, diagnostic criteria and might not otherwise receive a CRPS diagnosis. These patients would more likely fall into a CRPS-NOS (not otherwise specified) diagnosis because they do not meet all of the criterium. Not considering CRPS-NOS as a diagnosis could ultimately lead to an inaccurate diagnosis, ineffective treatment, and poor long-term outcomes.
Results:During a fourteen-month period, patients that were experiencing multiple symptoms of CRPS were identified and referred to a CRPS specialist for confirmatory diagnosis and treatment. Each of the patients underwent a series of peripheral sympathetic nerve blocks which ceased, or at least significantly decreased, patient symptomatology.
Conclusion:This case series is a small sample size of patients that were successfully treated with a series of peripheral sympathetic nerve blocks and adjunct therapy for CRPS. CRPS is a difficult disease process to manage, often with invasive means of treatment such as sympathetic ganglion blockade, intrathecal pump, spinal cord stimulator and/or pharmacologics. Peripheral sympathetic nerve blockade can be a powerful diagnostic and treatment tool for patients suffering from CRPS.
Keywords:Complex Regional Pain Syndrome; CRPS, neuropathic pain; Sympathetic nerve blockade; Pain management
Introduction
Complex Regional Pain Syndrome (CRPS) is a pain condition
that is often controversial in definition and treatment approach [1,2].
While early identification is important for appropriate and effective
management [3,4] there are different methods of diagnosis which
may yield different diagnostic conclusions [5].
The most accepted diagnostic criterium is developed by the
International Association for the Study of Pain (IASP), the “Budapest
Criteria”. The nature of this consensus criterium is to set a framework
and standard for diagnosing CRPS [3,4]. The challenge for clinicians
is those patients who do not fit into typical CRPS presentation. These
patients could be left without a diagnosis, or effective treatment,
leading to long-term disability [6,7].
The IASP Budapest Criteria states for a diagnosis of CRPS to
be made patients3:has continuing pain which is disproportionate to
any inciting event. The patient reports at least one symptom in three
or more categories below, displays at least one sign in two or of the
categories below and no other diagnosis can better explain the signs
and symptoms. Categories include:
1. Sensory: allodynia and/or hyperalgesia
2. Vasomtor: temperature asymmetry, skin color changes/ asymmetry
3. Sudomotor: edema and/or sweating.
4. Motor/Trophic: decrease range of motion, trophic changes such as hair, nail, skin and motor dysfunction such as weakness, tremor, dystonia.
1. Sensory: allodynia and/or hyperalgesia
2. Vasomtor: temperature asymmetry, skin color changes/ asymmetry
3. Sudomotor: edema and/or sweating.
4. Motor/Trophic: decrease range of motion, trophic changes such as hair, nail, skin and motor dysfunction such as weakness, tremor, dystonia.
CRPS has two categories, CRPS-I and CRPS-II. Both present
similarly but the precipitating event is different. CRPS-I usually
develops after a noxious event and pain is often disproportionate
to the inciting event with no specific nerve injury. CRPS-II is often
precipitated after injury to specific nerve. In CPRS-II, an ephapse
(neuroma) can often be identified [8]. Both types often have similar
symptoms [2,3,4,7].
CRPS should be viewed as a “disease on a spectrum rather than a
binary option” [5,7].
For patients who may not meet the strict diagnostic criteria of
“Budapest” CRPS-I or CRPS-II, there is a third category: CRPSNOS
(not otherwise specified)3. CRPS-NOS includes patients that
have some of the typical CRPS symptoms but may not meet all of the
qualifying signs and symptoms, and there is no other explanation for
their pain.
Furthermore, CRPS has two pain types: sympathethetically
maintained pain and sympathetically independent pain [9]. “CRPS
sympathetically maintained pain occurs together with swelling,
hyperesthesia, allodynia, burning dysesthesia, and temperature, color,
and trophic changes to the extremity. These signs and symptoms may
be inconsistent, presenting not at all, alone or in any combination.
However, any pain which is relieved by and is responsive to
sympathetic blockade is by definition sympathetically maintained
pain [9].”
“CRPS sympathetically independent pain patients will present
with classic symptoms and signs (CPRS)but will be unresponsive to
sympathetic blockade. Although not entirely understood, a potential
explanation for this phenomenon is that the disease process has
become centrally maintained only [9].”
Lastly, CRPS can further be defined as “warm” or “cold”: warm
CRPS is characterized by a warm, red, edematous, and sweaty
extremity while cold CRPS is characterized by a cold, blue, and less
edematous extremity [10]. Warm CRPS is often associated with an
acute bout of the disease process while cold is associated with chronic
CRPS [10]. However, early stage cold CRPS findings are often
associated with poor clinical outcomes [11].
The onset of CRPS has a distal predominance and is more
common in females (4:1) compared to men. CRPS onset can be due
to fractures, surgery, repetitive sprains/strains, burn injuries, limb
immobilization (casting), penetrating injuries, or infection [2,4].
Methods
Patient data was obtained retrospectively from electronic health
records review at the Southern California University of Health
Sciences (SCU) Tactical Sports Medicine Clinic. The period of
patient-clinician interaction began October 1, 2021, and ended May
1, 2023. All of the patients were diagnosed with CRPS-NOS at SCU
and referred to the office of Edward Carden, MD (Carden). Per direct
communication with Carden, he is a trained anesthesiologist and
has specialized in treatment and management of CRPS for over forty
years.
Utilizing the most common symptoms of CRPS, using Budapest
Criteria as a guide, a clinical diagnosis of CRPS-NOS was made
when a patient displayed two or more of the following: pain
disproportionate to precipitating injury, temperature differences at
the site of injury compared to the contralateral side(temperature was
ascertained via an infrared thermometer, IP22 model FT-F41),poor
range of motion at the affected limb, burning pain, hypersensitivity
or allodynia, deep throbbing pain which often wakes at night,
edema or swelling, discoloration, previous trauma, fracture and/or
immobilization, trophic changes [2,35,7,9] mirroring pain
[12],detection of possible ephapse was considered and could be helpful in
diagnosis of CRPS-II [8].
An ephapse is a site, typically in the peripheral nervous system,
where an abnormal, pathological synapse occurs between the somatic
nervous system and the autonomic nervous system. The theory of an
ephapse, or neuroma, is that it may generate ectopic activity to the
dorsal horn [8]. Though this theory of CRPS is controversial, it should
not be overlooked entirely.
CRPS pathophysiology has many hypotheses including an
inappropriate inflammatory response, altered cutaneous innervation,
central and peripheral sensitization, altered sympathetic nervous
system function, and/or an increase in local circulating catecholamines
[2,9,13]. These many hypotheses suggest that a multifaceted approach
to care is imperative for mitigation of symptoms and treatment of the
disease.
This case series highlights the importance of identifying the
presence of CRPS-NOS in our patients, no matter how subtle the
signs and symptoms. Once CRPS-NOS has been identified, an
appropriate referral is made to a chronic pain management specialist
for further evaluation. Each patient was then treated via peripheral
sympathetic block with saline solution and a dilute Marcaine solution.
The location of the sympathetic block was determined based on the
suspected origin site of CRPS.
Administering location for each peripheral sympathetic block was
determined by Carden based on each individual case presentation and
his clinical evaluation. The injection was performed with a 27-gauge
needle, ultrasound guidance and electrostimulation for needle
placement. Unless otherwise specified, each injection contained 10 cc
of saline and 0.025% Marcaine solution.
Adjunct therapy for the patient varied but included oral
alendronate (75mg) [14,15], clonidine patches (.1%) [16], and
followed with manual therapy and therapeutic exercise when
appropriate. Instituting therapeutic exercise into the management
plan was approached judiciously as aggressive active care can often
increase patient symptomatology [2,4].
Results
Patient 1:
A 25-year-old male presented to the office with right lateral
ankle pain of five years. He reports chronic right ankle pain that has
undergone three failed surgical procedures (1. syndesmosis repair, 2.
anterior talo-fibular ligament repair and 3. exploratory surgery), pain
management (cortisone injection, platelet rich plasma), acupuncture
treatment, joint manipulation, and physical therapy. The patient
would take 5000mg of ibuprofen per day to help alleviate his pain.
The patient reported waking every night due to throbbing pain, he
suffers burning pain, allodynia at the ankle, intermittent swelling and
sweating at the ankle with atrophy of the right lower leg.Examination findings include direct palation of the ankle led to
immediate edema, perspiration and became cold to touch. The patient
had restricted ankle range of motion compared to the uninvolved
side. Additionally, light pressure palpationto a small area inferior
to the fibula referred pain proximal to anteromedial thigh (possible
phapse). Due to these findings, a referral was made to Carden.
Carden confirmed the diagnosis of complex regional pain
syndrome with a peripheral sympathetic block on the right femoral
nerve at the groin. Following the patient’s initial injection, the
treatment gave the patient 24-hours of complete pain relief, which
was the first relief he had experienced in years.
The patient underwent a series of injections, in conjunction
with oral alendronate (70 mg)once per week and 0.1%mg clonidine
patches about the suspected ephapse, with management of symptoms.
This patient’s symptomatology drastically reduced, allowing him to
sleep through the night and return to normal activities of daily living.
He intermittently returns to receive a peripheral sympathetic block
which can produce one full month without symptoms.
Patient 2:
A 45-year-old female who had been under our care for a left fibular
fracture began developing significant pain after she was taken out of a
hard cast. The patient was in a hard cast for six weeks total. Once out
of the cast CT imaging with 3D construction was performed. The CT
revealed: “distal fibular oblique fracture demonstrating findings of
partial nonunion. There is approximate 60% of healing at the fracture
site.” The patient was now experiencing pain disproportionate to a
typical bone healing timeline.The patient suffered nighttime throbbing pain, burning pain, and
a sensation of swelling. Examination findings included focal allodynia
about the site of previous fracture, while her symptomatic ankle
was 31.1oC compared to 34.2oC on the contralateral side. Lastly, a
suspected ephapse1 was located that mirrored pain to the contralateral
ankle [12]. Due to these findings, a referral was made to Carden where
a sympathetic blockade was performed at the posterior tibial nerve.
Following the injection, the pain in the ankle reduced to 0/10
and the patient was then allowed to get up and leave. At that point,
she had full range of motion in the toes, feet, and the ankle. She
underwent a total of twelve injections, in conjunction with oral
alendronate (70 mg) once per week and 0.1%mg clonidine patches
about the suspected ephapse.
The patient remains symptom free 18 months later.
Patient 3:
A 35-year-old male developed burning pain ten weeks post-left
Achilles tendon debridement. The patient was placed in a hard cast
for six weeks following surgery, and then placed in a controlled ankle
motion (CAM) boot. During the time he was in a CAM boot, and
beginning post-operative therapy, burning pain developed.Clinical examination included discovery of an ephapse about the
surgical incision site, direct palpation to this site mirrored his pain to
the contralateral ankle [19]. The patient’s left ankle temperature was
measured at 31.2oC compared to 34.6oC right. Due to the increased
pain level, burning pain and temperature difference, a referral was
made to Carden.
Carden provided a diagnostic sympathetic block to the left ankle
at the posterior tibial nerve, following the procedure, the patient
reported eight hours pain free. The patient underwent a series of
peripheral sympathetic blocks to the left posterior tibial nerve, with
each injection giving the patient progressively longer periods pain
free until the pain resolved.
The patient’s management with Carden included oral alendronate
(70 mg) once per week and local 0.1%mg clonidine patches. The
patient’s pain remained minimal, and he was able to participate in a
full post-operative rehabilitation program.
Patient 4:
A 29-year-old female presented to this facility with right upper
extremity pain. The patient was involved in a motor vehicle accident
(MVA) where multiple injuries were sustained. She was initially
treated by another provider for cervical spine instability, concussion,
and left rotator cuff strain. Due to her ongoing right shoulder pain,
she was referred to this facility for a clinical work-up.The patient had right shoulder burning pain, poor shoulder
range of motion, specifically flexion and described “pain” at the right
shoulder with light touch. During the examination, allodynia at the
upper arm was found, the right shoulder temperature was measured
at 32.4oC compared to the contralateral side of 34.1oC. Due to the
dystonia, allodynia and temperature difference, a referral was made
to Carden.
Just prior to her initial consult with Carden, she did undergo
an MR Arthrogram of the shoulder and the most relevant findings
included:
1. Mild to moderate supraspinatus tendinosis with small, focal
low grade articular sided tearing at the posterior supraspinatus and
anterior footprints. No full thickness tear or retraction is evident.
Preserved muscle bulk. 3. Mild glenohumeral joint capsulitis. The
patient reported that her symptoms increased after the gadolinium
injection.
Carden provided diagnostic confirmation and treatment of CRPS
with a right sided interscalene sympathetic block to the brachial
plexus. The pain in the right upper extremity ceased while performing
the injection. Immediately following the injection, the patient was
able to perform full shoulder flexion.
She was given Alendronate 70 mg, one tablet weekly and
Clonidine Transdermal Patch 0.1% mg, one patch weekly. The patient
underwent a total of five interscalene blocks and the pain resolved as
did the dystonia.
Patient 5:
A 34-year-old female presented with chronic left knee pain. After
a comprehensive history, physical examination, and MRI, the patient
was diagnosed with Grade III jumper’s knee [17] and posterolateral
corner instability. She was referred to an extremity orthopedic
surgeon and concurrently commenced care consisting of manual
therapy, rehabilitation and PRP injection of the patellar tendon.
The patient did not respond well to conservative care and ultimately
required surgery to repair the patellar tendon and posterolateral
capsule of the knee. During the post-operative rehabilitation process,
the patient’s passive and active knee flexion did not improve past
100o in the subsequent weeks and she began to complain of “extreme
sensitivity” at the medial incision site with burning pain.The physical examination revealed allodynia along the medial
aspect of the left knee, and direct palpation to the incision site
referred pain proximal (ephapse). The aforementioned dystonia of
the left knee was present. Surface temperature of the left knee was
31.5o C and the contralateral side was 33.0o C. The patient was then
referred to Carden.
Carden confirmed the diagnosis of CRPS by blocking the
infrapatellar branch of the saphenous nerve with 3 cc saline/0.025%
Marcaine solution. The patient did not have immediate improvement
in the symptoms. However, at the next visit for post-operative
therapy, the patient had a significant improvement in knee flexion
to 120o, she reported a decrease in pain and symmetric temperature
from right to left knee. The patient’s CRPS symptoms did not return
after one treatment.
Patient 6:
A 34-year-old female developed post-operative “stinging” pain
10 weeks after left ankle arthroscopy to repair occult instability. The
patient was placed in a hard cast for six-weeks post-operatively. Once
removed, she was placed in a CAM boot for six additional weeks
with little to no post-operative therapy. Once therapy began, during
isometric exercise, she reported “stinging” pain at the lateral ankle
about the incision site. This was closely monitored over a two-week
period; however, the “stinging” pain began to wake her at night. She
also reported an increase in pain after rehabilitation therapy.The clinical examination revealed there was a temperature
difference of 32.7o C and the uninvolved side was 34.1o C, and the
left ankle was cold and clammy to the touch. Due to the increase in
pain with exercise, “stinging” pain and temperature differences, a
referral was made to Carden where a peripheral sympathetic block
was performed to the posterior tibial nerve.
Immediately after injection the pain level reduced and remained
absent for six days before returning, but at a lower level than
previously. The patient commenced a series of six sympathetic
blockades to the posterior tibial nerve. The patient was also be placed
on Alendronate 70 mg, one tablet weekly and Clonidine Transdermal
Patch 0.1% mg, one patch weekly through resolution of symptoms.
Patient 7:
A 26-year-old male developed an abnormal amount of pain six
weeks post-right knee arthroscopy. Prior to that development, the
patient had been progressing on a normal post-operative trajectory.
The knee range of motion was adequate, and he showed no signs
of infection. The patient had ceased taking pain medication and
completed the full course of doxycycline.The patient began waking at night due to deep, throbbing pain.
Allodynia followed at the anteromedial aspect of the knee, and his
range of motion began to regress which is indicative of dystonia. In
addition to these findings, his symptomatic knee was measured at
32.1oC compared to the contralateral knee at 34.6oC. A referral was
made to Carden, due to the suspected diagnosis of complex regional
pain syndrome.
Carden confirmed the diagnosis of CRPS with a peripheral
blockade at the ipsilateral femoral nerve with a 20cc solution.
Immediately following the procedure, the patient was able to
ambulate normally without pain from the knee distal to the plantar
aspect of the foot.
This patient underwent a series of thirteen peripheral sympathetic
blocks utilizing the saline solution. It was observed that each block
adehada compounding therapeutic effect, meaning each treatment
typically lasted longer than the previous injection. The treatment
began as oncer per week and evolved to oncer per month. The patient
was placed on oral alendronate (70 mg) oncer per week and 0.1%mg
clonidine patches about the suspected ephapse (ipsilateral knee).
Patient 8:
A 45-year-old male developed deep, throbbing pain at night
only, six weeks post-left knee arthroscopy. During the post-operative
rehabilitation process, he successfully gained adequate range of
motion at the knee. We closely monitored his symptoms once he
informed us of his night pain. He also developed tingling about the
knee.During a re-examination a likely ephapse was located at one
of the incision sites, it referred pain proximally to the anterior hip.
Additionally, there was hypersensitivity about the infrapatellar branch
of the saphenous nerve. No temperature difference was detected. The
deep aching night pain was most problematic. Pain medication did
not help with this pain. A referral was made to Carden.
Carden confirmed the diagnosis of CRPS with an injection to the
posterior tibial nerve at the popliteal fossa. Following this injection,
he stated the knee tingling, and the throbbing in the leg ceased
immediately, and the numbness in two or three of the toes on the left
side also disappeared.
Additionally, the patient was placed on oral alendronate (70 mg)
once per week and 0.1%mg clonidine patches about the suspected
ephapse. The patient underwent five peripheral sympathetic blocks
and reported complete solution of symptoms.
Patient 9:
A 54-year-old female developed intermittent burning pain four
weeks post-right cubital tunnel release. The patient was undergoing
successful post-operative therapy, which included manual therapy
and range of motion exercises when she began to regress in her care.
She then reported poor sleep due to deep, throbbing pain that would
wake her at night. These symptoms did not improve with over-the counter
pain medication.The patient began to experience abnormal hair growth and
allodynia at the site of incision. She could no longer partake in
post-operative therapy as most motions increased her pain level
significantly. Her right forearm was 32.0oC while her left arm was
34.1oC.
The patient then began to report mirroring pain, consisting
of the same symptoms in the asymptomatic arm. The patient was
referred to Carden for evaluation.
Carden provided an ipsilateral inter scalene brachial plexus
blockade. Immediately after the injection, the pain ceased in the arm,
elbow, wrist, hand and thereby confirming the diagnosis of complex
regional pain syndrome.
Additionally, the patient was placed on oral alendronate (70 mg)
oncer per week and 0.1%mg clonidine patches about the suspected
ephapse. The patient underwent five peripheral sympathetic blocks
and reported resolution of symptoms.
Patient 10:
A 36-year-old male developed dystonia and a cold sensation at
the right second finger post-traumatic distal phalanx amputation.
During a motor vehicle accident, the patient suffered an amputation
at the right second distal interphalangeal joint. The patient’s wound
was appropriately cleaned and managed with a prescription of antibiotics
at the emergency room. In the subsequent months, the patient
developed burning pain, throbbing pain at night and difficulty flexing
the entire finger.Examination revealed that his right index finger was 33.1oC
while the contralateral finger was 35.1oC. Dystonia was present in the
affected finger. These findings coupled with the subjective findings
warranted a referral to a chronic pain specialist.
Carden confirmed the diagnosis of CRPS with an ipsilateral
brachial plexus blockade. Immediately post-injection the pain in
the right hand diminished with improvement in range of motion of
the digits of the hand. He could now close his fist while prior to the
injection he could not.
The patient required two peripheral sympathetic blocks before
resolution of symptoms.
Patient 11:
A 44-year-oldfemale presented with sharp burning pain and
swelling on the anterolateral left foot. The patient’s ankle pain began
after standing on her feet for a sixteen-hour shift. The patient has
a history of a gunshot wound at the foot, and the bullet fragments
were removed surgically two years prior.Clinical examination revealed areas of hyper pigmentation
and swelling of skin around anterolateral ankle. The right foot was
33.40C while the right foot was 32.10C.A likely ephapse was present
at the dorsum of the foot at the 1-2 metatarsal space which radiated
proximally to the lateral ankle with direct palpation. The patient was
then referred to Carden for an evaluation and sympathetic blockade
to the posterior tibial nerve at the knee.
Following peripheral sympathetic blockade, the patient reported
complete resolution of pain. She underwent a series of these injections
to the left posterior tibial nerve; each injection provided the patient
longer periods pain relief.
The patient is currently undergoing continued care with Carden,
which includes posterior tibial sympathetic nerve blocks once per
week, oral alendronate once per week and local clonidine patches.
The patient is now getting up to one week of full pain relief with each
peripheral sympathetic block.
Discussion
This case series illustrates a repeatable method of clinical
diagnosis, and a minimally invasive approach to confirm the
diagnosis and manage CRPS. The first and most important aspect
of the case series is clinical recognition of a patient with CRPS. Not
confining our clinical judgment by the strict Budapest Criteria, each
patient was clinically diagnosed with CRPS-NOS if they displayed
two or more of the following: pain disproportionate to precipitating
injury, temperature differences at the site of injury compared to the
contralateral side, poor range of motion at the affected limb, burning
pain, hypersensitivity or allodynia, deep throbbing pain which often
wakes them at night, edema or swelling, discoloration, previous
trauma, fracture and/or immobilization, trophic changes, mirroring
pain [12], and/or presence of an ephapse.
The specifics of the peripheral sympathetic blockades are outlined
with each patient interaction discussed above. The sympathetic
blockade relieves symptoms of CRPS “by reducing circulating
nor epinephrine” which “in turn (reduces) tone and output of the
mechanoreceptors” [9]. With a decrease in mechanoreceptor output,
there is now decreased input at the dorsal horn and spinal cord.
Adjunct therapy of Alendronate was taken once per week. While
not fully understood, alendronate has been shown “effective in
improving pain, physical function and oedema in patients presenting”
with CRPS [14,15]. Mani court et al. proposed the alendronate
reduces “local acceleration of bone remodeling, (alendronate) might
relieve pain by effects on nociceptive primary afferents in bone”
[15].Clonidine patches are placed around the suspected site of origin of
CRPS as the “peripheral nerves generate ectopic impulses, which are
sensitive to adrenergic agonist. These nerve terminals are inhibited
from releasing norepinephrine upon adrenergic agonist binding”
[16].
This is not a novel approach, thus have been multiple case
studies published that document the efficacy of a peripheral nerve
block for treatment of CRPS [18,19]. Moreover, “Lam, Reeves and
Cheng” utilize a dextrose hydro dissection method that has shown
to be efficacious in treatment of CRPS [20].Prior to more invasive
approaches to treating CRPS, we postulate that a less invasive route
be explored for management of the disease.
Conclusion
Complex Regional Pain Syndrome can be debilitating for patients
that suffer with the disease process, who often go years without an
accurate diagnosis which can lead to long term disability and poor
quality of life. We do not contest that utilizing the Budapest Criteria
as a framework to help diagnose but recognize the strict nature
and rigid adherence to it may leave patients without an accurate
diagnosis. The signs and symptoms of CRPS can often be subtle. This
case series outlines a group of patients with CRPS-NOS that have
been managed via a series of peripheral sympathetic nerve blocks and
adjunct pharmacologics followed by manual therapy while under the
peripheral sympathetic block.
Treatment of CRPS is limited and the diagnosis is often
contentious unless it meets the standards of the Budapest Criteria.
Often, management of this disease process can be invasive with
treatment such as pharmacologics and/or spinal cord stimulator. We
postulate that treatment options for patients with CRPS symptoms
should include a more conservative approach utilizing peripheral
sympathetic nerve blockade as described in this case series.
While the literature is scant for this type of treatment method,
high-quality research is needed to further demonstrate its efficacy.
Acknowledgements
Internal Review Board Approval was ascertained for this case
series. All authors have no conflicts of interest or financial ties to
disclose. The results of the study are presented clearly, honestly, and
without fabrication, falsification, or inappropriate data manipulation.
We would also like to acknowledge Shelby Kloiber DC, CCSP® and her
valuable input and constructive feedback during the editing process